ResearcherOur Lady of Lourdes HospitalActive in the last 2 years

David J. Easty

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5108463781. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2026: 1 paper

Papers 1

Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in adv… Co-author DOI 10.1186/s12885-025-14512-2 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Derek Gerard Power · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Patrick Glyn Morris · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Bryan T. Hennessy · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Ray McDermott · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗
Adrian Gerard Murphy · 1 shared paper, 2026 · strength 0.23
- Paper Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemci… DOI 10.1186/s12885-025-14512-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.